Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

Inclusion Criteria

• •Hospital admission and diagnosis compatible with Malignant Bowel Obstruction, as defined below:
• •1. A diagnosis of primary ovarian cancer, primary peritoneal cancer or fallopian tube cancer
• •2. At least two of the following four symptoms: (a) vomiting (\>2 episodes in past 24 hours), (b) abdominal pain, (c) not passing gas per rectum in past 24 hours, (d) severe constipation (no bowel movement \>24 hours).
• •3. CT findings suggestive of complete bowel obstruction. CT Abdomen: confirms diagnosis of bowel obstruction (93% sensitivity 93-100% specificity) and aids in determining the location and etiology of obstruction.
• •Non-surgical candidate
• •Ability to understand and the willingness to sign a written informed consent document.
• •Patients must be 18 years of age or older.
• •ECOG performance status 0, 1 or 2 (Karnofsky \> or = 60%) one week prior to admission.
• •Patients must have adequate hematological function as defined below:
• •Absolute granulocyte count \> or = 1.5 x 10\^9/L
• •Platelet count \> or = 100 x 10\^9/L
• •Patients must have adequate renal and hepatic function as defined below:
• •Serum creatinine \< or = 1.5 x ULN OR a calculated creatinine clearance \> or = 50 ml/min
• •Bilirubin \< or = 3 x ULN, AST \< or = 5 x ULN, ALT \< or = 5 x ULN